Jacobio Pharmaceuticals repurchases shares, boosts treasury holdings

On November 11, 2025, Jacobio Pharmaceuticals Group Co., Ltd. executed a repurchase of 72,000 ordinary shares on the exchange. The shares were bought at prices ranging from HK$6.69 to HK$6.72, with an aggregate cost of HK$482,307. This transaction represents 0.00915% of the company's existing issued shares before the event.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased to 787,206,780 from an opening balance of 787,278,780. Concurrently, the number of treasury shares increased by 72,000, bringing the total to 4,548,300. The total number of issued shares remains unchanged at 791,755,080.

The repurchase was conducted under a mandate granted on June 10, 2025, which authorized the company to repurchase up to 78,873,528 shares. To date, 1,528,500 shares have been repurchased under this mandate, representing 0.19379% of the issued shares at the resolution date. A moratorium period for new share issues or treasury share sales is in effect until December 11, 2025.